ABEONA THERAPEUTICS INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $78.4M | $23.4M | $14.5M | $14.2M | $32.9M | $12.6M | $129.3M | $18.8M |
| Accounts Receivable | $6.1M | — | — | — | $3.0M | — | — | $81.0K |
| Inventory | $5.5M | — | — | — | — | — | — | — |
| Total Current Assets | $204.9M | $100.9M | $55.7M | $53.1M | $56.3M | $97.7M | $132.4M | $88.9M |
| Property, Plant & Equipment | $9.9M | $4.4M | $3.5M | $5.7M | $12.3M | $11.3M | $13.2M | $9.4M |
| Goodwill | — | — | — | — | — | $32.5M | $32.5M | $32.5M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | $1.4M | $1.5M | $36.2M | $43.0M |
| Total Assets | $219.6M | $108.9M | $64.0M | $64.2M | $79.6M | $151.2M | $223.4M | $174.4M |
| Liabilities | ||||||||
| Accounts Payable | $7.9M | $3.4M | $1.9M | $1.8M | $4.3M | $4.7M | $3.8M | $6.1M |
| Total Current Liabilities | $29.6M | $16.6M | $13.4M | $7.8M | $16.6M | $42.0M | $38.7M | $20.4M |
| Long-Term Debt | $7.8M | $13.0M | — | — | — | — | — | — |
| Total Liabilities | $60.4M | $64.9M | $49.2M | $37.5M | $37.2M | $48.6M | $45.0M | $40.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-742.1M | $-813.3M | $-749.5M | $-695.3M | $-655.6M | $-570.7M | $-486.5M | $-410.2M |
| Total Stockholders' Equity | $159.2M | $44.0M | $14.8M | $26.8M | $42.4M | $102.6M | $178.4M | $134.0M |